Yulin Ren | Health Professions | Excellence in Innovation Award

Dr. Yulin Ren | Health Professions | Excellence in Innovation Award

Sr. Research Scientist | The Ohio State University | United States

Dr. Yulin Ren is a leading researcher at The Ohio State University, Columbus, United States, with expertise in medicinal chemistry, natural product research, pharmacology, and anticancer drug discovery. His research focuses on isolating and characterizing bioactive natural compounds and evaluating their therapeutic potential against cancer and cardiovascular diseases. Dr. Ren has contributed a substantial body of peer-reviewed publications that have gained international recognition for their scientific rigor and translational relevance. His work spans studies on cardiac glycosides, alkaloids, and plant-derived bioactive molecules, highlighting innovative strategies for developing next-generation therapeutics. Collaborating extensively with a wide network of interdisciplinary and international researchers, he integrates chemistry, biology, and pharmacology to advance drug discovery and translational research. Dr. Ren’s contributions have meaningful societal impact by offering new avenues for effective cancer and cardiovascular treatments, promoting public health, and fostering innovation in medicinal chemistry. His research exemplifies a bridge between laboratory discoveries and clinical applications.

Citation Metrics (Scopus)

1925
1500
1000
500
0

Citations

1,925

Documents

67

h-index

25

Citations

Documents

h-index

View Google Scholar Profile View Scopus Profile

Featured Publications


Development of anticancer agents from plant-derived sesquiterpene lactones

– Current Medicinal Chemistry, 2016 (Citations: 186)

Guillermo Docena | Health Professions | Research Excellence Award

Dr. Guillermo Docena | Health Professions | Research Excellence Award

Investigador Principal | Universidad Nacional de La Plata | Argentina

Dr. Guillermo Horacio Docena is a distinguished immunologist at the Instituto de Estudios Inmunológicos y Fisiopatológicos, CONICET–Universidad Nacional de La Plata, Argentina. His research expertise lies in immunopathology, mucosal and cellular immunology, inflammatory processes, host–pathogen interactions, and vaccine-related immune responses. His scholarly work spans both fundamental and translational research, addressing topics such as neuroinflammation, extracellular vesicles, immune modulation using nanocarriers, food allergy, pediatric immune disorders, and immunogenicity of vaccination strategies. Dr. Docena is widely recognized for his sustained scientific contributions and strong international visibility, reflected in extensive peer-reviewed publications and high citation impact. He actively collaborates with researchers across disciplines and countries, strengthening global research networks in immunology and biomedical sciences. His research has contributed to improved understanding of immune mechanisms and has supported the development of innovative therapeutic and preventive approaches, demonstrating meaningful societal and public health relevance worldwide.

Citation Metrics (Scopus)

1901
1500
1000
500
0

Citations

1,901

Documents

69

h-index

26

Citations

Documents

h-index

View Google Scholar Profile
View Scopus Profile
View ORCID Profile

Featured Publications

Gwendolyn Quinn | Medicine and Dentistry | Best Researcher Award

Prof. Dr. Gwendolyn Quinn | Medicine and Dentistry | Best Researcher Award

Professor| New York University| United States

Dr. Gwendolyn P. Quinn is an internationally recognized behavioral scientist and bioethicist whose research focuses on patient–provider communication, reproductive ethics, and quality of life among cancer patients, particularly adolescents, young adults, and sexual and gender minority populations. She is Professor and Vice Chair of Research in the Departments of Obstetrics and Gynecology and Population Health at the New York University Grossman School of Medicine, where she also holds the Livia Wan Endowed Chair and is a member of the Division of Medical Ethics and the Perlmutter Cancer Center. Dr. Quinn’s work integrates behavioral science, ethics, and public health to enhance communication about reproductive health, genetics, and fertility preservation for individuals undergoing gonadotoxic treatment. She directs the NCI-funded ENRICH/ECHO training program, which improves oncology providers’ communication skills in reproductive and genetic health, and has contributed to national and international guidelines for ASCO, ASRM, and the PANCARE Life consortium. With more than 450 peer-reviewed publications—approximately 300 focused on reproductive health and bioethics—Dr. Quinn has significantly influenced research and practice in oncofertility, ethics, and cancer survivorship. She has served on the Board of Scientific Counselors for the National Institute of Environmental Health Sciences and holds fellowships in the American Association for Cancer Education and the New York Academy of Medicine. Her numerous honors, including the American Psychosocial Oncology Society’s Outstanding Education and Training Award, reflect her sustained leadership and impact on advancing equitable reproductive health care, ethical medical practice, and the education of future generations of researchers and clinicians worldwide.

Profiles: Google Scholar |Scopus | ORCID

Featured Publications

Loren, A. W., Mangu, P. B., Beck, L. N., Brennan, L., Magdalinski, A. J., Partridge, A. H., … & Quinn, G. P. (2013). Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. Journal of Clinical Oncology, 31(19), 2500–2510. Cited by: 1,901

Oktay, K., Harvey, B. E., Partridge, A. H., Quinn, G. P., Reinecke, J., Taylor, H. S., … & Loren, A. W. (2018). Fertility preservation in patients with cancer: ASCO clinical practice guideline update. Journal of Clinical Oncology, 36(19), 1994–2001. Cited by: 1,663

Quinn, G. P., Sanchez, J. A., Sutton, S. K., Vadaparampil, S. T., Nguyen, G. T., Green, B. L., … & Schabath, M. B. (2015). Cancer and lesbian, gay, bisexual, transgender/transsexual, and queer/questioning (LGBTQ) populations. CA: A Cancer Journal for Clinicians, 65(5), 384–400. Cited by: 551

Quinn, G. P., Vadaparampil, S. T., Lee, J. H., Jacobsen, P. B., Bepler, G., Lancaster, J., & Keefe, D. L. (2009). Physician referral for fertility preservation in oncology patients: A national study of practice behaviors. Journal of Clinical Oncology, 27(35), 5952–5957. Cited by: 490

Nahata, L., Tishelman, A. C., Caltabellotta, N. M., & Quinn, G. P. (2017). Low fertility preservation utilization among transgender youth. Journal of Adolescent Health, 61(1), 40–44. Cited by: 345

 

Dr. Gwendolyn P. Quinn’s pioneering work in reproductive ethics, patient–provider communication, and oncofertility has transformed clinical practice and education worldwide, advancing equitable reproductive health care for cancer patients and sexual and gender minorities. Her research and training initiatives have shaped global guidelines and strengthened ethical, compassionate communication in medicine.

Felicia Antohe | Health Professions | Excellence in Research

Dr. Felicia Antohe | Health Professions | Excellence in Research

Head of Proteomics Department at Inst. Cellular Biology and Pathology NS, Romania

Dr. Felicia Antohe, a distinguished researcher and Head of the Proteomics Department at the Institute of Cellular Biology and Pathology, Romanian Academy, is a highly suitable candidate for the Excellence in Research Award. With a Ph.D. in Cellular Biology and over 170 scientific publications, including 90 indexed in Web of Science and over 2,500 citations, she has made significant contributions to biomedical sciences. Her expertise spans proteomics, vascular biology, monoclonal antibody technology, and molecular mechanisms of macromolecular transport. Dr. Antohe has led over 44 national and international research projects, mentored numerous Ph.D. students, and held key roles in prestigious European scientific committees, including as an expert evaluator for EC Framework Programs. Recognized globally with multiple international awards and fellowships, her work has advanced knowledge in atherosclerosis, immune disorders, and endothelial cell biology. Her strong leadership, innovative research, and dedication to scientific excellence make her an exemplary candidate for this honor.

Professional Profile 

Education🎓

Dr. Felicia Antohe holds a robust academic background in the life sciences, beginning with a Master’s degree in Biophysics from the University of Bucharest, Faculty of Physics, completed between 1972 and 1977. She later pursued her doctoral studies at the Romanian Academy’s Institute of Cellular Biology and Pathology (IBPC N. Simionescu), where she earned a Ph.D. in Cellular Biology between 1985 and 1994. In 2000, she was accredited as a Ph.D. Coordinator in Cellular Biology by the Romanian Academy and the Ministry of Education and Research. Her education has been complemented by extensive international training and research fellowships at prestigious institutions such as McGill University (Canada), University of Alberta (Canada), Max Planck Institute (Germany), and Université René Descartes (France), among others. This rich educational foundation has equipped Dr. Antohe with interdisciplinary expertise spanning biophysics, molecular biology, immunology, and proteomics, laying the groundwork for her prolific and impactful scientific career.

Professional Experience📝

Dr. Felicia Antohe has an extensive and distinguished professional background in biomedical research, currently serving as Head of the Proteomics Department at the Institute of Cellular Biology and Pathology “N. Simionescu” of the Romanian Academy. She has also led the Monoclonal Antibody Laboratory and serves as a Ph.D. Coordinator in Cellular Biology. With over four decades of experience, she has acted as Principal Investigator on more than 44 nationally and internationally funded research projects and has mentored numerous Ph.D. and postgraduate students. Her international experience includes research fellowships and visiting scientist roles at top institutions such as McGill University, University of Alberta, Max Planck Institute, and Université René Descartes. She has served as an expert evaluator for EU Framework Programs (FP6, FP7), contributed to national research councils, and held leadership roles in international scientific networks like COST and the Central and Eastern European Proteomic Conferences. Her work integrates academic leadership with pioneering research.

Research Interest🔎

Dr. Felicia Antohe’s research interests lie at the intersection of cellular biology, molecular biology, and biomedical sciences, with a particular focus on the vascular endothelium. Her work explores the molecular mechanisms of macromolecule transport across endothelial cells, including transcytosis and endocytosis, in both healthy and pathological conditions such as atherosclerosis, diabetes, and immune disorders. She is deeply engaged in the study of membrane microdomains—lipid rafts and caveolae—and their structural and functional roles in cellular signaling and transport. Dr. Antohe is also an expert in proteomics, utilizing mass spectrometry and bioinformatics to analyze endothelial cell proteins in health and disease. Her research extends into the biotechnology of monoclonal and polyclonal antibodies for diagnostic and therapeutic applications. With a strong foundation in immunochemistry, molecular diagnostics, and nanostructured materials, her interdisciplinary investigations contribute to advancing biomedical knowledge and improving clinical strategies for vascular and systemic inflammatory diseases.

Award and Honor🏆

Dr. Felicia Antohe has received numerous prestigious awards and honors in recognition of her outstanding contributions to biomedical research. Internationally, she was awarded the EURESCO Prize for her work on membrane dynamics, and received the BIO-RAD Laboratories Prize for valuable scientific contributions. Her research has been recognized with the IIIrd Award at the International Congress of Medical Sciences in Bulgaria, and the Best Poster Award at the 8th International Conference on Vascular Endothelium in Greece. She has also earned fellowships, including the ESF grant for EURESCO Conferences and a Summer School Fellowship in Scotland. Nationally, she received the esteemed Emil Racoviță Prize from the Romanian Academy and eight other awards from institutions such as the University of Bucharest and CNCSIS. Additionally, she has been an invited speaker at numerous global conferences and authored monographs featured in over 1,900 international libraries, cementing her influence in the scientific community.

Research Skill🔬

Dr. Felicia Antohe possesses an exceptional array of research skills, developed through decades of pioneering work in cellular biology and proteomics. Her technical expertise encompasses a broad range of advanced methodologies, including immunological techniques such as monoclonal antibody production, FACS, ELISA, and immunocytochemistry. She is highly proficient in molecular biology tools, including PCR, RT-qPCR, in situ hybridization, and plasmid transfection. Dr. Antohe is also skilled in cell biology practices like cell culture, fluorescence and electron microscopy, and animal modeling. Her proteomics capabilities include 1D and 2D SDS-PAGE, protein radio-labeling, scintillation and gamma counting, and mass spectrometry, coupled with strong bioinformatics analysis. She has also applied her knowledge to complex systems such as lipid rafts, transcytosis, and membrane receptor function. In addition to hands-on techniques, she excels in mentoring young scientists and PhD students, reflecting her strong leadership in research training and laboratory development.

Conclusion💡

Dr. Felicia Antohe is highly suitable for an Excellence in Research Award, particularly one recognizing:

  • Lifetime achievements

  • Biomedical innovation

  • Mentorship

  • Leadership in research ecosystems

Her academic depth, scientific rigor, and institutional leadership align strongly with the core mission of such an award. While certain modern metrics (e.g., recent societal impact or innovation transfer) could be elaborated more, these are secondary when weighed against the breadth and depth of her contributions.

Publications Top Noted✍️

  • Firan M., Bawdon R., Radu C., Ober R.J., Eaken D., Antohe F., Ghetie V., et al. (2001). The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of γ-globulin in humans. International Immunology, 13(8), 993–1002.
    📌 Citations: 404

  • Borvak J., Richardson J., Medesan C., Antohe F., Radu C., Simionescu M., et al. (1998). Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice. International Immunology, 10(9), 1289–1298.
    📌 Citations: 308

  • Simionescu M., Gafencu A., Antohe F. (2002). Transcytosis of plasma macromolecules in endothelial cells: a cell biological survey. Microscopy Research and Technique, 57(5), 269–288.
    📌 Citations: 272

  • Antohe F., Rădulescu L., Gafencu A., Gheţie V., Simionescu M. (2001). Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells. Human Immunology, 62(2), 93–105.
    📌 Citations: 204

  • Van Gool A., Corrales F., Čolović M., Krstić D., Oliver-Martos B., Antohe F., et al. (2020). Analytical techniques for multiplex analysis of protein biomarkers. Expert Review of Proteomics, 17(4), 257–273.
    📌 Citations: 95

  • Simionescu M., Antohe F. (2006). Functional ultrastructure of the vascular endothelium: changes in various pathologies. In: The Vascular Endothelium I, pp. 41–69.
    📌 Citations: 90

  • Manduteanu I., Voinea M., Antohe F., Dragomir E., Capraru M., Radulescu L., et al. (2003). Effect of enoxaparin on high glucose-induced activation of endothelial cells. European Journal of Pharmacology, 477(3), 269–276.
    📌 Citations: 85

  • Lixandru B.E., Cotar A.I., Straut M., Usein C.R., Cristea D., Ciontea S., Antohe F., et al. (2015). Carbapenemase-Producing Klebsiella pneumoniae in Romania: A Six-Month Survey. PLoS ONE, 10(11), e0143214.
    📌 Citations: 66

  • Antohe F., Dobrila L., Heltianu C., Simionescu N., Simionescu M. (1993). Albumin-binding proteins function in the receptor-mediated binding and transcytosis of albumin across cultured endothelial cells. European Journal of Cell Biology, 60(2), 268–275.
    📌 Citations: 66

  • Haraba R., Suica V.I., Uyy E., Ivan L., Antohe F. (2011). Hyperlipidemia stimulates the extracellular release of the nuclear high mobility group box 1 protein. Cell and Tissue Research, 346, 361–368.
    📌 Citations: 53